PROCTER & GAMBLE Co 4

Robert Jones Portman received an award of 52 Procter & Gamble Co. RSUs valued at roughly $7,500 as part of routine equity compensation.

On September 8, 2026, Robert Jones Portman reported an award of 52 Restricted Stock Units (RSUs) of Procter & Gamble Co. common stock, granted under The Procter & Gamble 2025 Stock and Incentive Compensation Plan, which also includes dividend equivalent RSUs. The transaction is coded as an acquisition (A) of derivative-equivalent securities at no purchase price, reflecting routine equity compensation rather than an open-market trade. Following this grant, Portman beneficially owns approximately 5,246.6454 shares (or share-equivalent units) on a direct basis; using the current market price of about $143.43 per share, this implies post-transaction holdings worth roughly $752,000. The incremental award itself is modest, with an estimated value of about $7,500 at the current share price, and does not indicate a discretionary purchase or sale in the open market.

Filing Facts

CIK

80424

Ticker

PG

Form

4

Source Type

sec

Accession

0000080424-26-000166

Alert Tier

4